Diana Boehm

<scp>NOTCH</scp>, <scp>ASCL1</scp>, p53 and <scp>RB</scp> alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas

Lydia Meder, Katharina König, Luka Ozretić et al. · International Journal of Cancer · 2015 · 174 citations · Full text

Cancer Research, Primary Sclc, Rare Secondary Sclc +15

FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers

Friederike Göke, Alina Franzen, Trista K. Hinz et al. · Clinical Cancer Research · 2015 · 84 citations · Full text

Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck

Friederike Göke, Maike Bode, Alina Franzen et al. · Modern Pathology · 2013 · 57 citations · Full text

Oncology, Squamous Cell Carcinoma, Common Event +10

Somatic copy number alterations by whole‐exome sequencing implicates <i><scp>YWHAZ</scp></i> and <i><scp>PTK2</scp></i> in castration‐resistant prostate cancer

Roopika Menon, Mario C. Deng, Kerstin Rüenauver et al. · The Journal of Pathology · 2013 · 49 citations

Genetics, Amplification Frequency, Molecular Genetics +18

Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using Fibroblast Growth Factor Receptor Inhibitors

Friederike Göke, Alina Franzen, Roopika Menon et al. · CHEST Journal · 2012 · 48 citations

Antifibrotic Therapy, Medicine, Pharmacology +9